Salvage Chemotherapy for Refractory and Relapsed Posttransplant Lymphoproliferative Disorders (PTLD) After Treatment With Single-Agent Rituximab
暂无分享,去创建一个
B. Dörken | R. Hetzer | P. Reinke | N. Babel | H. Lehmkuhl | H. Riess | M. Hummel | R. Trappe | I. Anagnostopoulos | S. Jonas | S. Oertel | M. Papp-Váry | M. Papp‐Váry